skimmianine has been researched along with Esophageal Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fu, G; Guo, XW; Hao, H; Kang, L; Li, BJ; Liu, Y; Shi, SM; Zhang, XZ; Zhang, Y; Zhao, HF; Zheng, GN | 1 |
1 other study(ies) available for skimmianine and Esophageal Neoplasms
| Article | Year |
|---|---|
Skimmianine as a novel therapeutic agent suppresses proliferation and migration of human esophageal squamous cell carcinoma via blocking the activation of ERK1/2.
Topics: Animals; Cell Line, Tumor; Cell Movement; Cell Proliferation; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Gene Expression Regulation, Neoplastic; Humans; MAP Kinase Signaling System; Mice; Mice, Nude; Molecular Docking Simulation; Quinolines | 2022 |